Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 200 shares, a growth of 100.0% from the October 15th total of 100 shares. Based on an average daily trading volume, of 300 shares, the short-interest ratio is currently 0.7 days.
Aspen Pharmacare Trading Down 2.1 %
Shares of APNHY opened at $9.47 on Thursday. The firm has a fifty day moving average of $10.70 and a 200-day moving average of $11.95. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.81 and a quick ratio of 1.07. Aspen Pharmacare has a 1 year low of $9.26 and a 1 year high of $13.69.
Aspen Pharmacare Cuts Dividend
The company also recently announced a dividend, which was paid on Tuesday, October 8th. Shareholders of record on Friday, September 20th were given a $0.1202 dividend. The ex-dividend date was Friday, September 20th.
Aspen Pharmacare Company Profile
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.
Featured Articles
- Five stocks we like better than Aspen Pharmacare
- Transportation Stocks Investing
- Rocket Lab is the Right Stock for the Right Time
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Insider Buying Explained: What Investors Need to Know
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.